A new program at the University of Colorado Cancer Center provides individual mentoring to patients and caregivers to provide additional support through the cancer journey. Meet Kaitlyn Cavanaugh, the Imerman Angels Program Ambassador for Colorado.
In the featured article in the December issue of Nature Reviews Cancer, Dr. Graham describes the emerging field of TAM family kinases and their potential as therapeutic targets in leukemia and other forms of cancer.
Speaking at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, Dr. Pollyea summarized the latest results for AG-120, an exciting new drug for the treatment of patients with advanced leukemia.
Israel has the highest BRCA+ prevalence of any nation. Rabinovitch will deliver lectures and collaborate with health professionals who have expertise with the BRCA+ population in Israel.